Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096200
Filing Date
2024-08-13
Accepted
2024-08-13 16:10:05
Documents
55
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bolt-20240630.htm   iXBRL 10-Q 1710512
2 EX-31.1 bolt-ex31_1.htm EX-31.1 13128
3 EX-32.1 bolt-ex32_1.htm EX-32.1 6615
  Complete submission text file 0000950170-24-096200.txt   7118439

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20240630.xsd EX-101.SCH 920208
57 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20240630_htm.xml XML 1412307
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39988 | Film No.: 241201500
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)